Article
Heterozygous TYROBP deletion (PLOSLFIN) is not a strong risk factor for cognitive impairment.
Neurobiology of aging - 1 Apr 2018
Kaivola Karri, Jansson Lilja, Saarentaus Elmo, Kiviharju Anna, Rantalainen Ville, Eriksson Johan G, Strandberg Timo E, Polvikoski Tuomo, Myllykangas Liisa, Tienari Pentti J
Abstract excerpt
Biallelic loss-of-function mutations in TYROBP and TREM2 cause a rare disease that resembles early-onset frontotemporal dementia with bone lesions called polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL). Some PLOSL-causing variants in TREM2 have also been associated with Alzheimer's disease when heterozygous. Here, we studied the PLOSLFINTYROBP deletion that covers 4 of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
